|
|
|
|
letter to editor: expected impact of biosimilars on the pharmaceutical companies
|
|
|
|
|
|
|
|
نویسنده
|
golshani shiva ,faramarzi mohammad ali
|
|
منبع
|
iranian journal of medical sciences - 2021 - دوره : 46 - شماره : 5 - صفحه:399 -401
|
|
|
|
|
|
|
|
آدرس
|
tehran university of medical sciences, faculty of pharmacy, department of pharmaceutical biotechnology, department of drug and food control, iran, tehran university of medical sciences, faculty of pharmacy, department of pharmaceutical biotechnology, iran
|
|
پست الکترونیکی
|
faramarz@tums.ac.ir
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|